Kristin E. Criner, MD, Adjunct Clinical Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University, provided expert insight to Reuters Health on osteoporosis drug denosumab and serious adverse events of infections, after the medication was the subject of a systematic review and meta-analysis published in the Journal of Clinical Endocrinology and Metabolism. Dr. Criner was not involved in the review and meta-analysis or in the FREEDOM Trial and Extension referenced in the piece. Medscape, MD Alert, the Rheumatologist and the Annals of Long-Term Care picked up the Reuters Health article.